Supernus Pharmaceuticals reported 0.43 in EPS Earnings Per Share for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Eps Change
Abbott ABT:US $ 1.4 0.23
Adamas Pharmaceuticals ADMS:US -0.27 0.09
Aerie Pharmaceuticals AERI:US -0.67 0.05
Ani Pharmaceuticals ANIP:US $ 0.67 0.37
Antares Pharma ATRS:US 0.03 0.01
Aphria Inc APH:CN -1.14 0.72
Aurora Cannabis Inc ACB:CN -0.68 0.14
Bristol Myers Squibb BMY:US $ 1.93 0.19
Canopy Growth Corp WEED:CN 0.84 2.69
Cara Therapeutics CARA:US -0.61 0.14
Corcept Therapeutics CORT:US 0.21 0.03
Eisai 4523:JP Y 147.07 157.71
Eli Lilly And LLY:US $ 1.87 0
Endo International Ordinary Shares ENDP:US $ 0.65 0.08
Gw Pharmaceuticals GWPH:US $ -0.05 0.91
Horizon Pharma HZNP:US $ 1.62 1.59
JAZZ PHA JAZZ:US $ 3.9 0.02
Lannett LCI:US $ -0.19 0.21
Marinus Pharmaceuticals MRNS:US $ -0.65 0.09
Pacira Pharmaceuticals PCRX:US $ 0.77 0.24
Perrigo Ordinary Shares PRGO:US $ 0.5 0
Pfizer PFE:US $ 1.07 0.14
Revance Therapeutics RVNC:US -1.07 0.01
Supernus Pharmaceuticals SUPN:US 0.43 0.32
Teva Pharmaceutical Industries TEVA:US $ 0.59 0.04
United Therapeutics UTHR:US $ 3.65 3.04
Xeris Pharmaceuticals Inc XERS:US -0.41 0.11